...
首页> 外文期刊>Intensive care medicine >Prophylactic N-acetylcysteine decreases serum CRP but not PCT levels and microalbuminuria following major abdominal surgery. A prospective, randomised, double-blinded, placebo-controlled clinical trial.
【24h】

Prophylactic N-acetylcysteine decreases serum CRP but not PCT levels and microalbuminuria following major abdominal surgery. A prospective, randomised, double-blinded, placebo-controlled clinical trial.

机译:大腹部手术后,预防性N-乙酰半胱氨酸降低血清CRP,但不降低PCT水平和微量白蛋白尿。一项前瞻性,随机,双盲,安慰剂对照的临床试验。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: Our objective was to investigate whether short-term infusion of the oxygen free radical scavenger N-acetylcysteine (NAC) administered before and during extensive abdominal surgery could ameliorate the progression of early systemic inflammatory response. DESIGN: Prospective, randomised, double-blinded, placebo-controlled clinical trial. SETTING: Twenty-bed intensive care unit in a university hospital. PATIENTS: Following written informed consent, 100 patients were randomised into NAC and placebo groups. Three patients from the NAC group and four from the placebo group withdrew before the final analysis. INTERVENTION: The treatment group (n=47) received NAC (150 mg/kg(-1) bolus followed by a continuous infusion of 12 mg/kg(-1)/h(-1)) and the placebo group ( n=46) received the same volume of 5% dextrose during surgery. MEASUREMENTS AND RESULTS: Serum procalcitonin (PCT), C-reactive protein (CRP) and microalbuminuria was monitored preoperatively, on admission to ICU, then daily during the first 3 postoperative days. For statistical analysis Mann Whitney and Chi-squared tests were used. Patients' clinical course was similar in each group as monitored by the Multiple Organ Dysfunction Scores. There was no significant difference between the two groups regarding PCT and microalbuminuria at any assessment point. Significantly lower CRP levels were found in the NAC group on days 1 and 2 (t(24): median: 84.5 interquartile range: [62-120] vs. 118 [86-137] mg/l; p=0.020; t(48): 136 [103-232] vs. 195 [154-252] mg/l; p=0.013, NAC vs. placebo respectively). CONCLUSION: In this study, short-term NAC treatment decreased CRP levels, but failed to attenuate any other inflammatory response, as monitored by serum PCT and microalbuminuria. Overall, our results do not support the routine prophylactic use of NAC as a free radical scavenger in abdominal surgery.
机译:目的:我们的目的是调查在广泛的腹部手术之前和期间短期输注氧自由基清除剂N-乙酰半胱氨酸(NAC)是否可以改善早期全身炎症反应的进程。设计:前瞻性,随机,双盲,安慰剂对照的临床试验。地点:一所大学医院的二十张重症监护室。患者:书面知情同意后,将100例患者随机分为NAC组和安慰剂组。在最终分析之前,NAC组的三名患者和安慰剂组的四名患者退出。干预:治疗组(n = 47)接受NAC(150 mg / kg(-1)推注,然后连续输注12 mg / kg(-1)/ h(-1))和安慰剂组(n = 46)在手术期间接受了相同体积的5%葡萄糖。测量和结果:术前,入ICU时监测血清降钙素(PCT),C反应蛋白(CRP)和微量白蛋白尿,然后在术后头3天每天进行监测。为了进行统计分析,使用了曼惠特尼检验和卡方检验。通过多器官功能障碍评分监测,各组患者的临床病程相似。在任何评估点,两组在PCT和微量白蛋白尿方面均无显着差异。 NAC组在第1天和第2天发现CRP水平显着降低(t(24):中位数:84.5四分位间距:[62-120]和118 [86-137] mg / l; p = 0.020; t( 48):136 [103-232]相对于195 [154-252] mg / l; p = 0.013,NAC相对于安慰剂)。结论:在这项研究中,通过血清PCT和微量白蛋白尿监测,短期NAC治疗可降低CRP水平,但不能减弱任何其他炎症反应。总体而言,我们的结果不支持在腹部手术中常规预防性使用NAC作为自由基清除剂。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号